Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Liver Metastatic Model for Human Gastric Cancer Established by Orthotopic Tumor Cell Implantation

Liver Metastatic Model for Human Gastric Cancer Established by Orthotopic Tumor Cell Implantation We have established an orthotopic implantation model that is highly metastatic to the liver. A human gastric carcinoma cell line, AZ521, with low capacity for liver metastasis was implanted as a single-cell suspension in the stomach of nude mice. The tumor cells derived from a few liver metastatic foci were subsequently implanted orthotopically, and we established a cell line, AZH5G, by repeating the in vivo stepwise selection method. This metastasizing line (AZH5G) developed liver metastasis in seven of eight (87.5%) cases, whereas parental AZ521 developed in 3 of 20 (15.0%). The in vitro growth activities of AZH5G were lower than that of AZ521, although the in vivo tumorigenicity of AZH5G was clearly higher than that of AZ521. Motility assays demonstrated higher motility of AZH5G than of AZ521. Flow cytometric analysis demonstrated that the expression of α6-integrin significantly decreased in AZH5G (4.9% ± 4.1%) compared to in AZ521 (17.7% ± 8.1%) (p < 0.05). The adhesive activity of AZH5G cells to laminin was lower than that of AZ521 cells. In contrast, the adhesive activity of AZH5G cells to fibronectin was clearly higher than that of AZ521 cells. These findings suggested that changes in the expression of integrins on the cell surface might play an important role in metastatic ability. This well characterized line and its in vivo experimental model should be useful to investigate the mechanisms of liver metastasis and to develop a new therapeutic approach for human gastric cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Surgery Wiley

Liver Metastatic Model for Human Gastric Cancer Established by Orthotopic Tumor Cell Implantation

Liver Metastatic Model for Human Gastric Cancer Established by Orthotopic Tumor Cell Implantation

World J. Surg. 25, 131–137, 2001 DOI: 10.1007/s002680020047 WOR LD Journal of SURGERY © 2001 by the Socie ´te ´ Internationale de Chirurgie Liver Metastatic Model for Human Gastric Cancer Established by Orthotopic Tumor Cell Implantation Koji Yamaguchi, M.D., Hideki Ura, M.D., Takahiro Yasoshima, M.D., Takayuki Shishido, M.D., Ryuichi Denno, M.D., Koichi Hirata, M.D., Ph.D. First Department of Surgery, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo 060-8543, Japan Abstract. We have established an orthotopic implantation model that is tion from injection of the cell lines and disaggregated cells to highly metastatic to the liver. A human gastric carcinoma cell line, AZ521, transplantation with intact tissue because disaggregated cells sus- with low capacity for liver metastasis was implanted as a single-cell pensions may not always express their full metastatic potential [8, suspension in the stomach of nude mice. The tumor cells derived from a 9], thereby greatly reducing local tumor growth and metastatic few liver metastatic foci were subsequently implanted orthotopically, and we established a cell line, AZH5G, by repeating the in vivo stepwise capability. We have developed an orthotopic implantation model selection method. This metastasizing line (AZH5G) developed liver me- of human gastric carcinoma cells using a cell suspension tech- tastasis in seven of eight (87.5%) cases, whereas parental AZ521 devel- nique. Here we describe a cell line, designated AZH5G, with a oped in 3 of 20 (15.0%). The in vitro growth activities of AZH5G were highly metastatic potential to the liver in this report. To be able to lower than that of AZ521, although the in vivo tumorigenicity of AZH5G use it to study mechanisms of liver metastasis, we characterized was clearly higher than that of AZ521. Motility assays demonstrated higher motility of AZH5G than of AZ521. Flow cytometric analysis dem- the growth activity, cell...
Loading next page...
 
/lp/wiley/liver-metastatic-model-for-human-gastric-cancer-established-by-BTPbabRfDk

References (25)

Publisher
Wiley
Copyright
Copyright © 2001 by Société Internationale de Chirurgie
ISSN
0364-2313
eISSN
1432-2323
DOI
10.1007/s002680020047
Publisher site
See Article on Publisher Site

Abstract

We have established an orthotopic implantation model that is highly metastatic to the liver. A human gastric carcinoma cell line, AZ521, with low capacity for liver metastasis was implanted as a single-cell suspension in the stomach of nude mice. The tumor cells derived from a few liver metastatic foci were subsequently implanted orthotopically, and we established a cell line, AZH5G, by repeating the in vivo stepwise selection method. This metastasizing line (AZH5G) developed liver metastasis in seven of eight (87.5%) cases, whereas parental AZ521 developed in 3 of 20 (15.0%). The in vitro growth activities of AZH5G were lower than that of AZ521, although the in vivo tumorigenicity of AZH5G was clearly higher than that of AZ521. Motility assays demonstrated higher motility of AZH5G than of AZ521. Flow cytometric analysis demonstrated that the expression of α6-integrin significantly decreased in AZH5G (4.9% ± 4.1%) compared to in AZ521 (17.7% ± 8.1%) (p < 0.05). The adhesive activity of AZH5G cells to laminin was lower than that of AZ521 cells. In contrast, the adhesive activity of AZH5G cells to fibronectin was clearly higher than that of AZ521 cells. These findings suggested that changes in the expression of integrins on the cell surface might play an important role in metastatic ability. This well characterized line and its in vivo experimental model should be useful to investigate the mechanisms of liver metastasis and to develop a new therapeutic approach for human gastric cancer.

Journal

World Journal of SurgeryWiley

Published: Feb 24, 2014

There are no references for this article.